VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 468 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2015. The put-call ratio across all filers is 0.90 and the average weighting 1.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $2,000 | +100.0% | 70 | 0.0% | 0.00% | – |
Q1 2018 | $1,000 | 0.0% | 70 | 0.0% | 0.00% | – |
Q4 2017 | $1,000 | -75.0% | 70 | -74.1% | 0.00% | -100.0% |
Q3 2017 | $4,000 | -20.0% | 270 | 0.0% | 0.00% | -50.0% |
Q2 2017 | $5,000 | -37.5% | 270 | -62.8% | 0.00% | -33.3% |
Q1 2017 | $8,000 | -27.3% | 725 | 0.0% | 0.00% | -25.0% |
Q4 2016 | $11,000 | -15.4% | 725 | +38.1% | 0.00% | -33.3% |
Q3 2016 | $13,000 | +18.2% | 525 | 0.0% | 0.01% | +20.0% |
Q2 2016 | $11,000 | -21.4% | 525 | 0.0% | 0.01% | -28.6% |
Q1 2016 | $14,000 | -73.6% | 525 | 0.0% | 0.01% | -74.1% |
Q4 2015 | $53,000 | -43.6% | 525 | 0.0% | 0.03% | -47.1% |
Q3 2015 | $94,000 | -19.7% | 525 | 0.0% | 0.05% | -15.0% |
Q2 2015 | $117,000 | +12.5% | 525 | 0.0% | 0.06% | +13.2% |
Q1 2015 | $104,000 | +38.7% | 525 | 0.0% | 0.05% | +35.9% |
Q4 2014 | $75,000 | – | 525 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |